Concepedia

Linus N. Igwemezie

LN

Statistics

Publications

15

Citations

401

H-Index

13

Active since

1987

Affiliations

University of British Columbia(Current)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Germany)

Linus N. Igwemezie is an author at University of British Columbia specializing in medicine, pharmacokinetics, and pharmacology.

Top concepts

Publications per year

1987–1996

15

Publications

15

Stereoselective analysis of the enantiomers of mexiletine by high-performance liquid chromatography using fluorescence detection and study of their stereoselective disposition in man

Keith M. McErlane, Linus N. Igwemezie, C. R. Kerr · Journal of Chromatography B Biomedical Sciences and Applications · 1987 · 49 citations

, , +8

Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors.

Daniel R. Budman, Linus N. Igwemezie, Sanjeev Kaul et al. · Journal of Clinical Oncology · 1994 · 47 citations

The Pharmacokinetics of the Enantiomers of Mexiletine in Humans

Linus N. Igwemezie, C. R. Kerr, Keith M. McErlane · Xenobiotica · 1989 · 40 citations

Pharmacokinetics and bioequivalence of etoposide following intravenous administration of etoposide phosphate and etoposide in patients with solid tumors.

Sanjeev Kaul, Linus N. Igwemezie, Douglas Stewart et al. · Journal of Clinical Oncology · 1995 · 37 citations

Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.

G G Chabot, Jean‐Pierre Armand, C. Terret et al. · Journal of Clinical Oncology · 1996 · 33 citations

1–5 of 15